Olive AI’s Billion Dollar Bust: The Evidence-Free Fall of a Health AI Unicorn
The story of Olive AI is a cautionary tale for investors and health system CIOs navigating the burgeoning landscape of healthcare AI. Once heralded as…
AI in ED: Missed Diagnoses & Delayed Treatment Risks
The integration of artificial intelligence into emergency departments promised a revolution in diagnostic speed and treatment initiation, yet growing evidence suggests a more complex reality.…
Babylon Health’s $4.2 Billion Collapse: A Clinical Accuracy Post-Mortem
The cautionary tale of Babylon Health, a company that soared to a dizzying $4.2 billion valuation on the promise of AI-driven healthcare before collapsing into…
Healthcare AI Risks: Unmasking Failure Modes from Fraud to False Negatives
The promise of artificial intelligence in healthcare is transformative, yet the landscape is littered with cautionary tales where ambition outstripped validation. For investors and patient…
Healthcare AI’s Billion Dollar Graveyard: Theranos to Olive AI
The graveyard of healthcare AI is littered with cautionary tales, none more stark than the combined $1.847 billion that vanished with Theranos and Olive AI.…
Pulse Oximeter Bias: A Billion-Dollar Blind Spot in Cardiac AI
The promise of artificial intelligence in healthcare is often painted with broad strokes of efficiency and improved outcomes. Yet, a critical examination of documented failures…
Healthcare AI’s Bias Blind Spot: The Cost-Proxy Problem
The promise of artificial intelligence in healthcare is often framed in terms of efficiency and precision, yet a critical, often overlooked, dimension is its potential…
Meta Pixel Lawsuits: Hospital Data Shared with Facebook
The digital transformation of healthcare, while promising unprecedented efficiencies and insights, has introduced complex vulnerabilities, particularly concerning patient data privacy. The lawsuits surrounding Meta Pixel’s…
Pear Therapeutics: The Billion Dollar Digital Health Mirage
The narrative of Pear Therapeutics, once a beacon of digital health innovation, serves as a sobering case study for investors and regulatory officers alike. With…